{
  "trial_id": "NCT01804309",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "women with clinically node negative invasive or microinvasive breast cancer",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "18 years of age or older",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "previous ALND",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "clinically positive axillary SLNB",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "pregnant or lactating",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "neoadjuvant breast cancer treatment based on surgeon's discretion (ASCO)",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "45-year-old postmenopausal woman with HER2-positive and ER/PR-negative invasive ductal breast carcinoma, 5 positive lymph nodes, metastatic lesions on CXR.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT01804309",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}